Eli Lilly and Company

Nancy G Mayne

Robert L Sharp

Yvonne M Snyder

J Paul Burnett, Jr

James Paul Burnett, Jr

Hansen M Hsiung

Ramamoorthy Belegaje

This invention describes a novel human glutamate receptors, designated HmGluR3. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.

Excitatory amino acid receptor protein and related nucleic acid compounds

The present invention provides a human glutamate receptor and related DNA compounds useful not only in assays for potential pharmaceuticals but also in methods for molecular biology techniques.

Human glutamate receptor and related DNA compounds

Human glutamate receptor proteins and associated DNA compounds

This invention provides a human glutamate receptor and functional equivalents thereof, and nucleic acids compounds which encode the receptor. The invention also provides assays, probes and primers, and other molecular biology techniques which utilize the compounds disclosed.

Human metabotropic glutamate receptor and related DNA compounds

This invention describes two novel human glutamate receptors, designated mGluR5A and mGluR5B. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.

Isolated nucleic acid encoding a human mGluR5

This invention describes a novel human glutamate receptors, designated mGluR2. This invention also encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds.

Excitatory amino acid receptor protein expression testing methods

A recombinant DNA cloning vector useful for expressing exogenous protein is described, which comprises

Growing community of inventors

Indianapolis, IN, United States of America

Nancy G Mayne